J&J's Imaavy (nipocalimab-aahu) has received US Food and Drug Administration (FDA) approval for treating generalised ...

GSK said it remains confident it can absorb the financial impact of potential US tariffs as it posted a 4% rise in Q1 2025 ...

The slowdown in IPOs following tariff-associated turbulence and FDA reorganisation will soon pass, say industry investors.

Boehringer Ingelheim, along with the University of Oxford, UK, and Cumulus Neuroscience, has launched a study for BPD.

Data from the NERO study investigating Zejula in mesothelioma was presented at the American Association of Cancer Research ...

Biopharmaceutical drug company venture financing witnessed a downturn in Q1 2025 —a 20.2% decline from the $8.1bn raised in ...

While pharma manufacturing deals in the US increased, large cuts to research and regulatory agencies increased concerns for the sector.

Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...

When Donald Trump descended a golden escalator at Trump Tower in New York City in 2015 to announce the launch of his first ...

The situation began to escalate after Trump’s trade policy announcement on 5 April. The gold standard of business ...

The FDA has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).

The astronomical rise in popularity of GLP-1RAs in recent years has led to a shortage, prompting users to turn to compounders ...